Lead and develop a field sales team focused on post-bariatric hypoglycemia (PBH).
Own regional strategy and execution, translating brand priorities into territory plans.
Build relationships with health systems and metabolic care teams to drive patient support.
Amylyx is a clinical-stage biopharmaceutical company focused on developing treatments for diseases with high unmet needs, including post-bariatric hypoglycemia, Wolfram syndrome, and ALS. The company has an experienced team and a culture of caring, driven by core values of audacity, curiosity, and accountability.
Create awareness of Cycle Pharma treatment options and patient support services through physician, nurse, and office-based selling.
Engage accounts and HCPs via phone, email, video conferencing, and face-to-face interactions.
Execute quarterly territory business plans and collaborate with HUB, marketing, and medical affairs teams.
Cycle Pharmaceuticals develops and improves treatments for rare metabolic, immunological, and neurological genetic conditions. The company is headquartered in Cambridge, UK, with a significant US presence and was named one of the UK's fastest-growing private companies by The Sunday Times.
Own the overall rare disease franchise strategy, business performance, and P&L with full accountability for revenue, profitability, and commercial objectives.
Lead the commercial strategy and launch of RGX-202 while shaping the growth and evolution of the rare disease franchise.
Partner cross-functionally to turn strategy into execution and deliver meaningful outcomes for patients, providers, and the company.
We are a biotechnology company pioneering what's possible in gene therapy, advancing a pipeline of therapies for serious rare and retinal diseases. We are a growing company with a talented, collaborative team passionate about making a meaningful difference for patients and their families.